FE 999322

· Ferring Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FE 999322, covering 2024-10-18 to 2024-10-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis [Phase 1]

See pricing